CellSeed Inc. (7776.T)
JPY 551.0
(0.0%)
JPY 551.0
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 143.75 Million JPY | -4.96% |
| 2022 | 151.25 Million JPY | -4.72% |
| 2021 | 158.75 Million JPY | -0.78% |
| 2020 | 160 Million JPY | 0.0% |
| 2019 | - JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 139.37 Million JPY | -1.33% |
| 2024 Q1 | 141.25 Million JPY | -1.74% |
| 2023 Q2 | 147.5 Million JPY | -1.26% |
| 2023 Q4 | 143.75 Million JPY | -0.86% |
| 2023 Q1 | 149.37 Million JPY | -1.24% |
| 2023 FY | 143.75 Million JPY | -4.96% |
| 2023 Q3 | 145 Million JPY | -1.69% |
| 2022 Q3 | 153.12 Million JPY | 0.0% |
| 2022 FY | 151.25 Million JPY | -4.72% |
| 2022 Q4 | 151.25 Million JPY | -1.22% |
| 2021 FY | 158.75 Million JPY | -0.78% |
| 2020 FY | 160 Million JPY | 0.0% |
| 2019 FY | - JPY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 767.03 Million JPY | 81.259% |
| PRISM BioLab Co.,LTD | - JPY | -Infinity% |
| GNI Group Ltd. | 2 Billion JPY | 92.813% |
| Linical Co., Ltd. | 1.49 Billion JPY | 90.416% |
| Trans Genic Inc. | 1.32 Billion JPY | 89.168% |
| MEDINET Co., Ltd. | 781 Thousand JPY | -18305.89% |
| Soiken Holdings Inc. | - JPY | -Infinity% |
| Cytori Cell Research Institute, Inc. | 2.34 Billion JPY | 93.875% |
| AnGes, Inc. | 214.94 Million JPY | 33.124% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | -34.536% |
| Nxera Pharma Co., Ltd. | 63.21 Billion JPY | 99.773% |
| Immuno-Biological Laboratories Co., Ltd. | 84.56 Million JPY | -69.996% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | 87.037% |
| Carna Biosciences, Inc. | 28.4 Million JPY | -406.126% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 875.59 Million JPY | 83.583% |
| RaQualia Pharma Inc. | 39.05 Million JPY | -268.118% |
| Chiome Bioscience Inc. | - JPY | -Infinity% |
| Kidswell Bio Corporation | 1.83 Billion JPY | 92.179% |
| PeptiDream Inc. | 19.63 Billion JPY | 99.268% |
| Oncolys BioPharma Inc. | 161.1 Million JPY | 10.77% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | 397 Million JPY | 63.791% |
| Healios K.K. | 450 Million JPY | 68.056% |
| BrightPath Biotherapeutics Co., Ltd. | - JPY | -Infinity% |
| Kubota Pharmaceutical Holdings Co., Ltd. | - JPY | -Infinity% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 77.29 Million JPY | -85.985% |
| FunPep Company Limited | - JPY | -Infinity% |
| Kringle Pharma, Inc. | - JPY | -Infinity% |
| Stella Pharma Corporation | 773.29 Million JPY | 81.411% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | - JPY | -Infinity% |
| Cuorips Inc. | - JPY | -Infinity% |
| K Pharma,Inc. | - JPY | -Infinity% |
| Takara Bio Inc. | 788 Million JPY | 81.758% |
| ReproCELL Incorporated | - JPY | -Infinity% |
| PhoenixBio Co., Ltd. | 491.35 Million JPY | 70.744% |
| StemCell Institute Inc. | 6.67 Million JPY | -2053.235% |
| Japan Tissue Engineering Co., Ltd. | - JPY | -Infinity% |